Compare EMBJ & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMBJ | CRL |
|---|---|---|
| Founded | 1969 | 1947 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2B | 10.8B |
| IPO Year | 2006 | 1999 |
| Metric | EMBJ | CRL |
|---|---|---|
| Price | $75.55 | $278.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 12 |
| Target Price | $84.00 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 1.2M | 883.5K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.60 | $3.04 |
| P/E Ratio | $159.30 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $53.56 | $144.26 |
| 52 Week High | $80.75 | $288.02 |
| Indicator | EMBJ | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 69.10 | 74.48 |
| Support Level | $60.85 | $153.47 |
| Resistance Level | $80.75 | N/A |
| Average True Range (ATR) | 2.31 | 9.39 |
| MACD | 0.33 | 3.21 |
| Stochastic Oscillator | 66.62 | 84.23 |
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment. Geographically, the company operates in Brazil, Europe, Asia Pacific, North America, and Others.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.